Risk of malignancy index in the preoperative evaluation of pelvic masses

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 3, 2004, Pages 255-258

  Obeidat, B R ^a,b,c   Amarin, Z O ^a   Latimer, J A ^a   Crawford, R A ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b Cambridge Cancer Trials Centre   (United Kingdom)

^c NONE   (Jordan)

Author keywords

CA 125; Menopausal status; Risk of malignancy index

Indexed keywords

ADULT; ARTICLE; BODY MASS; CALCULATION; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MEDICAL ASSESSMENT; MENOPAUSE; PELVIS TUMOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ULTRASOUND;

EID: 2442449461     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2003.10.009     Document Type: Article

References (16)

1. Manjunath A.P., Pratapkumar, Sujatha K., Vani R. Comparison of three risk-of-malignancy indices in evaluation of pelvic masses. Gynecol Oncol. 81:2001;225-229
2. Yuen P.M., Yu K.M., Yip S.K., Lau W.C., Rogers M.S., Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol. 177:1997;109-114
3. Hacker N.F., Van der Burg M.E.L. Debulking and intervention surgery. Ann Oncol. 4:(Suppl):1993;17-22
4. Levin L., Lund B., Heintz A.M.P. An overview of multivariate analysis of prognostic variables with special reference to the role of cytoreductive surgery. Ann Oncol. 4:(Suppl):1993;23-29
5. Kehoe S., Powell J., Wilson S., Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Int J Cancer. 70:1994;1014-1017
6. Gillis C.R., Hole D.J., Still R.M., Davis J., Kaye S.B. Medical audit, cancer registration, and survival in ovarian cancer. Lancet. 337:1991;611-612
7. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., Grudzinskas J.G. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate pre-operative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 97:1990;922-929
8. Weiner Z., Thaler I., Beck D., Rottem S., Deutsch M., Brandes J.M. Differentiating malignant from benign ovarian tumours with transvaginal colour flow imaging. Obstet Gynecol. 79:1991;159-162
9. Kurjak A., Zalud I., Alfirevic Z. Evaluation of adnexal masses with transvaginal colour ultrasound. J Ultrasound Med. 10:1991;295-297
10. Bourne T., Campell S., Steer C., Whitehead M.I., Collins W.P. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. Br Med J. 299:1989;1367-1370
11. Kurjak A., Kupesic S., Anic T., Kosuta. Three-dimensional ultrasound and power Doppler improves the diagnosis of ovarian lesions. Gynecol Oncol. 76:2000;28-32
12. Gadducci A., Ferdeghini M., Prontera C., et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol. 44:1992;147-154
13. McGuckin M.A., Ramm L.E., Joy G.J., Free K.E., Ward B.G. Preoperative discrimination between ovarian carcinoma, non-ovarian gynaecological malignancy and benign adnexal masses using serum levels of CA125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA. Int J Gynecol Cancer. 2:1992;118-128
14. Jacobs I.J., Rivera H., Oram D.H., Base R.C. Differential diagnosis of ovarian cancer with tumour markers CA125, CA15-3 and TAG72.3. Br J Obstet Gynaecol. 100:1993;1120-1124
15. Davies A.P., Jacob I., Woolas R., Fish A., Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol. 100:1993;927-931
16. Tingulstad S., Hagen B., Skjeldestad F.E., et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 103:1996;826-883